Insulin Colombia

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 85 pages

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible for around 40% of the total where 5 main serogroups ACWY and B are responsible for the majority ...

Industries: Drug and Medication | Countries: World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • June 2014
  • 115 pages

Includes 3 FREE quarterly updates BMI View: The Colombian pharmaceutical industry is the fifth-largest in Latin America, a position that is expected to continue to solidify over the projection period. The country benefits from an improving regulatory position and has made itself as a distribution centre ...

Industries: Drug and Medication | Countries: Colombia

Farmasanitas Ltda in Retailing (Colombia)

Farmasanitas Ltda in Retailing (Colombia)

  • $ 153
  • Company report
  • by Euromonitor International
  • May 2014
  • 2 pages

Farmasanitas Ltda operates in four business areas: chemists/pharmacies which sell directly to the public, institutional sales to clinics and hospitals, contract sales with IPS (Instituciones Prestadoras de Servicios/Healthcare institutions) and outsourcing services for pharmacies of hospitals and clinics. ...

Industries: E-commerce, Drug and Medication | Countries: Colombia

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Colombia

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Colombia

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 38 pages

As ingredients such as pseudoephedrine were used to make some cold remedies but also as raw materials for some illegal drugs, as is the case of amphetamines, the Colombian government decided to withdraw it in May 2010. After this prohibition, although there is no evidence of it, there is the possibility ...

Industries: Drug and Medication | Countries: Colombia

Dermatologicals in Colombia

Dermatologicals in Colombia

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 37 pages

Advertising has been the catalyst that has activated some modestly growing and quite stable categories into more dynamic areas within the consumer health industry. It is important to note that there are no new medicines or delivery systems and this can be considered a revamp of old products for old problems. ...

Industries: Drug and Medication | Countries: Colombia

Nrt Smoking Cessation Aids Market Overview in Colombia

Nrt Smoking Cessation Aids Market Overview in Colombia

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 28 pages

After the enactment of an antitobacco law in May 2008, which does not allow smoking in closed spaces such as offices, restaurants and bars, there was an additional motivation for smokers to search for ways that could help them quit smoking. This fuelled NRT smoking cessation aids sales, giving those ...

Industries: Drug and Medication | Countries: Colombia

Analgesics Market Overview in Colombia

Analgesics Market Overview in Colombia

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 34 pages

There were important launches in analgesics as GlaxoSmithKline de Colombia offered new versions of Dolex. It shows how acetaminophen products are still the first choice for consumers when looking for a pain reliever. This is true despite the new launches in other types of analgesics such as ibuprofen ...

Industries: Drug and Medication | Countries: Colombia

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2014
  • 112 pages

BMI View: Colombia’s pharmaceutical and healthcare industry s will perform better than the regional average over the medium term due to its high urbanisation rate and population growth. Strong macroeconomic growth will be the fundamental driving force for behind this expansion. We expect the gradually ...

Industries: Drug and Medication | Countries: Colombia

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2013
  • 116 pages

Colombia’s newly elected government, led by President Juan Manuel Santos, will continue to re-establish diplomatic relations, resulting in the realignment of foreign policy focus from the US towards the Latin American region. BMI believes this shift in international policy will boost foreign investment, ...

Industries: Drug and Medication | Countries: Colombia

Colombia Business Projection Industry Update Quarter 4 2011

Colombia Business Projection Industry Update Quarter 4 2011

  • $ 1 208
  • Industry report
  • by Business Monitor International
  • September 2013
  • 49 pages

Core Views Broadly in line with consensus, we believe Colombia will become a regional outperformer by 2012. Private consumption will drive the majority of growth, although gross fixed capital formation will play an increasingly important role over the coming quarters. The banking, infrastructure, mining ...

Industries: Drug and Medication | Countries: Colombia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.